公司資料
Nemaura Medical 股價、新聞與催化劑
- 股票代碼:
- NMRD
- 交易所:
- PINK
- 產業:
- Biopharma
- 所在地:
- United Kingdom and trades in the U
股票表現
0.00 USD (-99.00%)
收盤價
最後更新: 2026年8月4日
—
市值
股價為何變動
Current closing-price context is not available for NMRD.
公司概覽
業務概覽
Nemaura Medical is a healthcare technology company focused on noninvasive glucose monitoring and chronic-disease management tools. Its story is built around the promise of sensor-based monitoring without traditional finger-stick workflows.
所在地與產業分類
Nemaura Medical is headquartered in the United Kingdom and trades in the U.S. market. It sits in medical technology and digital health rather than biotech therapeutics.
商業模式特徵
The business depends on product adoption, commercialization, and the ability to translate noninvasive monitoring into recurring usage. Investors focus on device rollout, reimbursement, and execution more than on drug-development catalysts.
生技產業定位
Nemaura sits in the chronic-care device and digital-monitoring layer of healthcare. It is not biotech proper, but it belongs to the broader health-tech stack where adoption and reimbursement matter most.
未來催化劑
- Nemaura Medical’s catalysts are diabetes-monitoring and metabolic-health products, plus any commercialization update that shows the platform can still gain traction. The company needs more visible adoption.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。